Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program
Conclusions:
Our data showed that, cabozantinib is a active and feasible treatment in patient with nonclear cell RCC.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Genitourinary Source Type: research
More News: Cancer & Oncology | Carcinoma | Hypothyroidism | Italy Health | Kidney Cancer | Renal Cell Carcinoma | Toxicology